SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-006493
Filing Date
2024-01-23
Accepted
2024-01-23 16:05:20
Documents
11
Period of Report
2024-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-20240122.htm   iXBRL 8-K 47001
2 EX-10.1 onct-ex10_1.htm EX-10.1 20360
  Complete submission text file 0000950170-24-006493.txt   213620

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onct-20240122.xsd EX-101.SCH 48182
5 EXTRACTED XBRL INSTANCE DOCUMENT onct-20240122_htm.xml XML 4715
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 24552513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)